Intelligent Extracorporeal Blood Treatment Systems

Publication ID: 24-11857715_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Extracorporeal Blood Treatment Systems,” Published Technical Disclosure No. 24-11857715_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857715_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,715.

Summary of the Inventive Concept

The inventive concept integrates extracorporeal blood treatment with advanced technologies like AI, IoT, blockchain, and nanomaterials to create a more efficient, secure, and patient-centric system.

Background and Problem Solved

The original patent describes an extracorporeal blood treatment apparatus with a blood-warming device. However, this design has limitations in terms of data security, real-time monitoring, and blood-borne pathogen reduction. The new inventive concept addresses these limitations by incorporating cutting-edge technologies.

Detailed Description of the Inventive Concept

The new system comprises a blood treatment device, a blood warmer, and an extracorporeal blood circuit with a heating zone. Additionally, it integrates a blockchain-based data storage module for secure patient treatment data tracking, an AI-powered predictive analytics module for optimized priming parameters, IoT-enabled sensors for real-time monitoring, a nanomaterial-based coating for reducing blood-borne pathogens, and a machine learning-based control module for real-time adjustment of blood treatment parameters. The system also features a decentralized, IoT-enabled monitoring network for remote patient monitoring.

Novelty and Inventive Step

The new claims introduce the innovative combination of extracorporeal blood treatment with AI, IoT, blockchain, and nanomaterials, providing a synergistic solution that surpasses the capabilities of the original patent. The inventive step lies in the integration of these distinct technologies to create a more efficient, secure, and patient-centric system.

Alternative Embodiments and Variations

Alternative embodiments may include different AI algorithms for predictive analytics, various nanomaterial-based coatings for pathogen reduction, or different IoT-enabled sensor configurations. Variations may also include the use of other advanced technologies, such as augmented reality or robotics, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of blood treatment, patient monitoring, and data security. The target market includes hospitals, clinics, and research institutions, with potential for expansion into home healthcare and telemedicine.

CPC Classifications

SectionClassGroup
A A61 A61M1/369
A A61 A61M1/3623
A A61 A61M1/3626
A A61 A61M1/3627
A A61 A61M1/3643
A A61 A61M39/28
A A61 A61M2205/3344
A A61 A61M2205/36

Original Patent Information

Patent NumberUS 11,857,715
TitleExtracorporeal blood treatment apparatus
Assignee(s)Gambro Lundia AB